Jasmin et al., 2021 - Google Patents
Myocardial viability imaging using manganese‐enhanced MRI in the first hours after myocardial infarctionJasmin et al., 2021
View PDF- Document ID
- 6640789734632270226
- Author
- Jasmin N
- Thin M
- Johnson R
- Jackson L
- Roberts T
- David A
- Lythgoe M
- Yang P
- Davidson S
- Camelliti P
- Stuckey D
- Publication year
- Publication venue
- Advanced science
External Links
Snippet
Early measurements of tissue viability after myocardial infarction (MI) are essential for accurate diagnosis and treatment planning but are challenging to obtain. Here, manganese, a calcium analogue and clinically approved magnetic resonance imaging (MRI) contrast …
- 208000010125 Myocardial Infarction 0 title abstract description 46
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7285—Specific aspects of physiological measurement analysis for synchronising or triggering a physiological measurement or image acquisition with a physiological event or waveform, e.g. an ECG signal
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/50—Clinical applications
- A61B6/507—Clinical applications involving determination of haemodynamic parameters, e.g. perfusion CT
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jasmin et al. | Myocardial viability imaging using manganese‐enhanced MRI in the first hours after myocardial infarction | |
Pislaru et al. | Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent | |
Laissy et al. | Differentiating acute myocardial infarction from myocarditis: diagnostic value of early-and delayed-perfusion cardiac MR imaging | |
Bengel et al. | Serial assessment of sympathetic reinnervation after orthotopic heart transplantation: a longitudinal study using PET and C-11 hydroxyephedrine | |
Camici et al. | Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium) | |
Ibrahim et al. | Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi | |
Kraitchman et al. | Stem cell therapy: MRI guidance and monitoring | |
Csonka et al. | Measurement of myocardial infarct size in preclinical studies | |
Antkowiak et al. | Noninvasive assessment of pancreatic β-cell function in vivo with manganese-enhanced magnetic resonance imaging | |
Hadamitzky et al. | The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT | |
Poulin et al. | Conversion of arterial input functions for dual pharmacokinetic modeling using Gd‐DTPA/MRI and 18F‐FDG/PET | |
Laurberg et al. | Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation | |
US20180271375A1 (en) | Robust myocardial blood oxygen level dependent magnetic resonance imaging with improved patient comfort | |
Krombach et al. | Contrast-enhanced MR delineation of stunned myocardium with administration of MnCl2 in rats | |
Zogbi et al. | Early postnatal rat ventricle resection leads to long‐term preserved cardiac function despite tissue hypoperfusion | |
US20190038781A1 (en) | Assessment of coronary heart disease with carbon dioxide | |
Stork et al. | Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate between acute and chronic myocardial infarction | |
Spath et al. | Manganese‐enhanced T1 mapping in the myocardium of normal and infarcted hearts | |
Ripa et al. | Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging | |
Meza et al. | Combination of dobutamine and myocardial contrast echocardiography to differentiate postischemic from infarcted myocardium | |
Saeed | New concepts in characterization of ischemically injured myocardium by MRI | |
Zhang et al. | Molecular imaging of myocardial necrosis: an updated mini-review | |
Moore | Advances in beta-cell imaging | |
Brewington et al. | Reproducible microvascular dysfunction with dobutamine infusion in Takotsubo cardiomyopathy presenting with ST segment elevation | |
Singh et al. | Manganese‐enhanced magnetic resonance imaging of the heart |